Holinka C F, Gurpide E
Am J Obstet Gynecol. 1984 Oct 15;150(4):359-63. doi: 10.1016/s0002-9378(84)80138-6.
The activity of diamine oxidase, the enzyme that catalyzes the oxidative deamination of putrescine, spermidine, histamine, and other substances involved in the regulation of cell proliferation and immune responses, increases up to 1000-fold in blood of pregnant women. In vivo experiments have shown that progestins stimulate diamine oxidase in the rodent uterus. We examined diamine oxidase activity in human endometrium at different phases of the menstrual cycle and in decidua from first-trimester pregnancies. Enzyme activity was also assayed in tissues and media of cultured human endometrium and decidua in the presence of estradiol or medroxyprogesterone acetate. Enzyme activity in first-trimester decidual tissues (286 +/- 86 mU of diamine oxidase per milligram of DNA; mean +/- SEM) was considerably higher (p less than 0.001) than that in endometrium (2.6 +/- 1.6), and the activity increased from 6 to 17 weeks of pregnancy. No significant differences were detected in proliferative and secretory endometrium. Activities in media of endometrium in organ culture generally were below detectability. Decidua secreted large amounts of the enzyme into the medium (160 to 600 mU per milligram of DNA per day), greatly exceeding the initial tissue activities. Bovine serum, when added to culture media, caused a marked increase in diamine oxidase levels, whereas estradiol (10(-8) mol/L) or medroxyprogesterone acetate (10(-6) mol/L) did not. Kinetic analysis showed a Michaelis constant of 7.4 X 10(-6) mol/L with putrescine as the substrate. Spermidine and histamine were competitive inhibitors of putrescine with an inhibition constant of 1.1 X 10(-4) and 3.5 X 10(-6) mol/L, respectively. These results demonstrate synthesis and export of diamine oxidase by decidua in organ culture, stimulation of activity by serum factors, and competition of histamine, spermidine, and putrescine for the enzyme.
二胺氧化酶可催化腐胺、亚精胺、组胺及其他参与细胞增殖和免疫反应调节的物质的氧化脱氨反应,其活性在孕妇血液中可增加至1000倍。体内实验表明,孕激素可刺激啮齿动物子宫中的二胺氧化酶。我们检测了月经周期不同阶段人子宫内膜及孕早期蜕膜中二胺氧化酶的活性。还在存在雌二醇或醋酸甲羟孕酮的情况下,对培养的人子宫内膜和蜕膜的组织及培养基中的酶活性进行了测定。孕早期蜕膜组织中的酶活性(每毫克DNA含286±86 mU二胺氧化酶;平均值±标准误)显著高于子宫内膜(2.6±1.6)(p<0.001),且该活性在妊娠6至17周时增加。增殖期和分泌期子宫内膜未检测到显著差异。器官培养的子宫内膜培养基中的活性通常低于可检测水平。蜕膜向培养基中分泌大量该酶(每天每毫克DNA 160至600 mU),大大超过初始组织活性。向培养基中添加牛血清会导致二胺氧化酶水平显著升高,而雌二醇(10⁻⁸mol/L)或醋酸甲羟孕酮(10⁻⁶mol/L)则不会。动力学分析表明,以腐胺为底物时米氏常数为7.4×10⁻⁶mol/L。亚精胺和组胺是腐胺的竞争性抑制剂,抑制常数分别为1.1×10⁻⁴和3.5×10⁻⁶mol/L。这些结果表明,器官培养中的蜕膜可合成并分泌二胺氧化酶,血清因子可刺激其活性,组胺、亚精胺和腐胺可竞争该酶。